ATNX News and Press, Athenex Inc. From 09/06/22

BUFFALO, N.Y., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Athenex (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that management will present...

Athenex is a biopharma that might get acquired, as buyout rumors have recently appeared. Reported acquisition price is in the $200m-$250m range, suggesting a 160%+ upside from the current price. Company sale seems likely as the company has a promising oncological treatment portfol...

Gainers: T2 Biosystems ( TTOO ) +73% . Veru ( VERU ) +38% . Ginkgo Bioworks ( DNA ) +21% . Inotiv ( NOTV ) +20% . Accuray ( ARAY ) +17% . Losers: Athenex ( ATNX ) -46% . Invitae ( NVTA ) -43% . Cer...

Athenex ( ATNX ) -41% on pricing $30M in stock and warrants offering . Invitae ( NVTA ) -25% . Hyperfine ( HYPR ) -17% on Q2 earnings release . Sonos ( SONO ) -17% on Q3 earnings release . Six Flags Entertainment ( SIX ) ...

Athenex ( NASDAQ: ATNX ) plunged 23.9% down premarket after it priced its underwritten public offering of 35.3M shares and accompanying warrants at a combined public offering price of $0.75/share and accompanying warrant, pre-funded warrants to purchase up to 4.67M shares ...

BUFFALO, N.Y., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc. (“Athenex”) (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announ...

Athenex ( NASDAQ: ATNX ) shares dropped over 41% during Wednesday's extended trading after the biopharmaceutical company proposed an underwritten public offering of common stocks and warrants. Terms of the offering are yet to be determined. The offering will consis...

BUFFALO, N.Y., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc. (“Athenex”) (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Eric Urquhart/Shutterstock.com We’re starting off the last day of trading this week with a breakdown of the biggest pre-market stock movers for Friday! Earnings reports, sale rumors, and an offer to t...

Buying Penny Stocks on August 5th? Here’s What You Need to Know With another week of trading penny stocks coming to an end, there is a lot that investors need to know. Already in August, we have seen a major amount of movement across the board with both penny stocks and blue ch...